Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only

NCT04148170 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04148170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04148170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only
Lead sponsor
Cairo University
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2020
Completion date
September 30, 2020
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital nasolacrimal duct obstruction